Market Overview

Life Stem Genetics, American CryoStem Announce Collaboration


Life Stem Genetics (OTC: LIFS) announced today a strategic
collaborative agreement with American CryoStem Corporation,
(OTC: CRYO). CRYO is a leading developer, marketer and global licensor
of patented adipose tissue-based cellular technologies for the
Regenerative and Personalized Medicine industries.

Adipose tissue is an anatomical term for loose connective tissue (fat)
composed of adipocytes (cells). It is used in LIFS stem cell procedures
and currently is extracted via liposuction each time a patient has a
treatment. This collaboration will give our physician's network the
ability to store a patient's adipose tissue for future regenerative
medicine applications after only one extraction process. In the absence
of future liposuction procedures, the patient's recovery time is

See full press release

Posted-In: News Guidance Contracts Management Global


Related Articles (CRYO + LIFS)

View Comments and Join the Discussion!